Immune-mediated diseases, including cancer and viral infections, continue to pose major global health challenges despite ...
Augurex’s abstract on anti-14-3-3eta autoantibodies earned the ADLM 2026 Immunology Abstract Award and was selected for a featured ePoster Discussion.
Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved ...
T cells are specialized immune cells designed to identify and eliminate disease. In the context of chronic inflammatory illness, such as infection or cancer, the body needs a constant presence of this ...
At the foot of the Collserola Natural Park in Barcelona, a pioneering institution has opened its doors. The CaixaResearch Institute is the first centre in Spain solely dedicated to advancing ...
The deal strengthens its immunology portfolio and accelerates AbbVie’s expansion into respiratory diseases through a pipeline of clinical-stage therapies targeting atopic dermatitis and asthma. AbbVie ...
This educational activity is intended for pulmonary specialists and other members of the health care team who care for patients with obstructive lung diseases such as COPD and asthma. Asthma and COPD ...
In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.
A parasitic worm might be the impetus behind a new generation of medicine. In a recent review in published in Clinical & Translational Immunology, Neima Briggs, MD, Ph.D., instructor of medicine ...
Your immune system needs constant support from healthy habits that can strengthen it. Here is a list of them that you should ...
Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible reason why. These brain scans of a 74-year-old patient with Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results